請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/61584
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳俊任(Chun-Jen Chen) | |
dc.contributor.author | Shu-Yu Hsu | en |
dc.contributor.author | 許書瑀 | zh_TW |
dc.date.accessioned | 2021-06-16T13:06:31Z | - |
dc.date.available | 2018-08-08 | |
dc.date.copyright | 2013-08-08 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-02 | |
dc.identifier.citation | 參考文獻
1. Jinn, T. R., C. M. Wu, W. C. Tu, J. L. Ko, and J. T. C. Tzen. 2006. Functional expression of FIP-gts, a fungal immunomodulatory protein from Ganoderma tsugae in Sf21 insect cells. Biosci Biotech Bioch 70: 2627-2634. 2. Lin, J. Y., M. L. Chen, and B. F. Lin. 2006. Ganoderma tsugae in vivo modulates Th1/Th2 and macrophage responses in an allergic murine model. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 44: 2025-2032. 3. Boh, B., M. Berovic, J. Zhang, and L. Zhi-Bin. 2007. Ganoderma lucidum and its pharmaceutically active compounds. 13: 265-301. 4. Kino, K., Akio,Y., K. Yamaoka, J. Watanabe, S. Tanaka, K. KO, K. Shimizu, and H. Tsunoo. 1989. Isolation and Characterization of a New Immunomodulatory Protein, Ling Zhi-8 (LZ-8), from Ganoderrna Zucidiurn. THE JOURNAL OF BIOLOGICAL CHEMISTRY 264: 472-478. 5. Hsu, H. C., C. I. Hsu, R. H. Lin, C. L. Kao, and J. Y. Lin. 1997. Fip-vvo, a new fungal immunomodulatory protein isolated from Volvariella volvacea. The Biochemical journal 323 ( Pt 2): 557-565. 6. Ko, J. L., C. I. Hsu, R. H. Lin, C. L. Kao, and J. Y. Lin. 1995. A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. European journal of biochemistry / FEBS 228: 244-249. 7. Xuanwei, Z., L. Qizhang, Y. Yizhou, C. Yiyuan, and L. Juan. 2008. Identification of medicinal Ganoderma species based on PCR with specific primers and PCR-RFLP. Planta medica 74: 197-200. 8. Chang, H. H., and F. Sheu. 2007. A novel fungal immunomodulatory protein (PCP) isolated from Poria cocos activates mouse peritoneal macrophage involved in toll-like receptor 4. Faseb J 21: A738-A738. 9. Li, F., H. Wen, X. Liu, F. Zhou, and G. Chen. 2012. Gene cloning and recombinant expression of a novel fungal immunomodulatory protein from Trametes versicolor. Protein expression and purification 82: 339-344. 10. Murasugi, A., S. Tanaka, N. Komiyama, N. Iwata, K. Kino, H. Tsunoo, and S. Sakuma. 1991. Molecular-Cloning of a Cdna and a Gene Encoding an Immunomodulatory Protein, Ling Zhi-8, from a Fungus, Ganoderma-Lucidum. J Biol Chem 266: 2486-2493. 11. Tanaka, S., K. Ko, K. Kino, K. Tsuchiya, A. Yamashita, A. Murasugi, S. Sakuma, and H. Tsunoo. 1989. Complete Amino-Acid Sequence of an Immunomodulatory Protein, Ling Zhi-8 (Lz-8) - an Immunomodulator from a Fungus, Ganoderma-Lucidium, Having Similarity to Immunoglobulin Variable Regions. J Biol Chem 264: 16372-16377. 12. Haak-Frendscho, M., K.Kino, T. Sone, and P. Jardieu. 1993. Ling Zhi-8 : a novel T cell mitogen induces cytokine production and upregulation of adhesion molecules. Biochem Bioph Res Co 186: 385-390. 13. Kino, K., T.Sone, J. Watanabe, A. Yamashita, H. Tsuboi, H. Miyajima, and H. Tsunoo. 1991. Immunomodulator, LZ-8, prevents antibody production in mice. International journal of immunopharmacology 13: 1109-1115. 14. Kino, K., K. Mizumoto, T. Sone, T. Yamaji, J. Watanabe, A. Yamashita, K. Yamaoka, K. Shimizu, K. Ko, and H. Tsunoo. 1990. An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice. Diabetologia 33: 713-718. 15. Lin, Y. L., Y. C. Liang, Y. S. Tseng, H. Y. Huang, S. Y. Chou, R. S. Hseu, C. T. Huang, and B. L. Chiang. 2009. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappa B and MAPK pathways. J Leukocyte Biol 86: 877-889. 16. Lin, W. H., C. H. Hung, C. I. Hsu, and J. Y. Lin. 1997. Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by a yeast two-hybrid system and site-directed mutagenesis. J Biol Chem 272: 20044-20048. 17. 林采蔆. 2005. 靈芝屬免疫調節蛋白 GMI 與 GFO-1 基因之選殖與 Pichia pastoris 之異源表現. In 臺灣大學微生物與生化學研究所學位論文. 臺灣大學. 1-80. 18. 吳明玥. 2008. 利用熱休克蛋白質5'端非轉譯區片段調控免疫調節蛋白質GMI於米麴菌表達系統之產量. In 臺灣大學微生物與生化學研究所學位論文. 臺灣大學. 1-101. 19. Lin, C. H., Y. M. Hsiao, C. C. Ou, Y. W. Lin, Y. L. Chiu, K. H. Lue, J. G. Chang, and J. L. Ko. 2010. GMI, a Ganoderma Immunomodulatory Protein, Down-regulates Tumor Necrosis Factor alpha-Induced Expression of Matrix Metalloproteinase 9 via NF-kappa B Pathway in Human Alveolar Epithelial A549 Cells. J Agr Food Chem 58: 12014-12021. 20. Lin, C. H., G. T. Sheu, Y. W. Lin, C. S. Yeh, Y. H. Huang, Y. C. Lai, J. G. Chang, and J. L. Ko. 2010. A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochem 45: 1537-1542. 21. Hsin, I. L., C. C. Ou, T. C. Wu, M. S. Jan, M. F. Wu, L. Y. Chiu, K. H. Lue, and J. L. Ko. 2011. GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells. Autophagy 7: 873-882. 22. 游耀萱. 2010. Ganoderma microsporum 免疫調節蛋白GMI 在動物體之免疫佐劑與抗微生物感染活性之研究. In 臺灣大學生化科技學系. National Taiwan University, 臺北市. 23. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 417-426. 24. Franchi, L., N. Wamer, K. Viani, and G. Nunez. 2009. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 227: 106-128. 25. Martinon, F., O. Gaide, V. Petrilli, A. Mayor, and J. Tschopp. 2007. NALP Inflammasomes: A central role in innate immunity. Semin Immunopathol 29: 213-229. 26. de Veerdonk, F. L. V., M. G. Netea, C. A. Dinarello, and L. A. B. Joosten. 2011. Inflammasome activation and IL-1 beta and IL-18 processing during infection. Trends Immunol 32: 110-116. 27. Elinav, E., T. Strowig, A. L. Kau, J. Henao-Mejia, C. A. Thaiss, C. J. Booth, D. R. Peaper, J. Bertin, S. C. Eisenbarth, J. I. Gordon, and R. A. Flavell. 2011. NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis. Cell 145: 745-757. 28. Chen, G. Y., M. C. Liu, F. Y. Wang, J. Bertin, and G. Nunez. 2011. A Functional Role for Nlrp6 in Intestinal Inflammation and Tumorigenesis. Journal of immunology 186: 7187-7194. 29. Vladimer, G. I., D. Weng, S. W. M. Paquette, S. K. Vanaja, V. A. K. Rathinam, M. H. Aune, J. E. Conlon, J. J. Burbage, M. K. Proulx, Q. Liu, G. Reed, J. C. Mecsas, Y. Iwakura, J. Bertin, J. D. Goguen, K. A. Fitzgerald, and E. Lien. 2012. The NLRP12 Inflammasome Recognizes Yersinia pestis (vol 37, pg 96, 2012). Immunity 37: 588-588. 30. Qiao, Y., P. Wang, J. Qi, L. Zhang, and C. Gao. 2012. TLR-induced NF-kappaB activation regulates NLRP3 expression in murine macrophages. FEBS letters 586: 1022-1026. 31. Bauernfeind, F. G., G. Horvath, A. Stutz, E. S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. H. Wu, B. G. Monks, K. A. Fitzgerald, V. Hornung, and E. Latz. 2009. Cutting Edge: NF-kappa B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression. Journal of immunology 183: 787-791. 32. Guarda, G., M. Zenger, A. S. Yazdi, K. Schroder, I. Ferrero, P. Menu, A. Tardivel, C. Mattmann, and J. Tschopp. 2011. Differential Expression of NLRP3 among Hematopoietic Cells. Journal of immunology 186: 2529-2534. 33. O'Connor, W., J. A. Harton, X. S. Zhu, M. W. Linhoff, and J. P. Y. Ting. 2003. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. Journal of immunology 171: 6329-6333. 34. Juliana, C., T. Fernandes-Alnemri, S. Kang, A. Farias, F. S. Qin, and E. S. Alnemri. 2012. Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation. J Biol Chem 287: 36617-36622. 35. Burckstummer, T., C. Baumann, S. Bluml, E. Dixit, G. Durnberger, H. Jahn, M. Planyavsky, M. Bilban, J. Colinge, K. L. Bennett, and G. Superti-Furga. 2009. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10: 266-272. 36. DeYoung, K. L., M. E. Ray, Y. A. Su, S. L. Anzick, R. W. Johnstone, J. A. Trapani, P. S. Meltzer, and J. M. Trent. 1997. Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene 15: 453-457. 37. Qu, Y., S. Misaghi, A. Izrael-Tomasevic, K. Newton, L. L. Gilmour, M. Lamkanfi, S. Louie, N. Kayagaki, J. F. Liu, L. Komuves, J. E. Cupp, D. Arnott, D. Monack, and V. M. Dixit. 2012. Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 490: 539-+. 38. Schroder, K., and J. Tschopp. 2010. The Inflammasomes. Cell 140: 821-832. 39. Ferrari, D., C. Pizzirani, E. Adinolfi, R. M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio. 2006. The P2X7 receptor: a key player in IL-1 processing and release. Journal of immunology 176: 3877-3883. 40. Elssner, A., M. Duncan, M. Gavrilin, and M. D. Wewers. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. Journal of immunology 172: 4987-4994. 41. Dostert, C., V. Petrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677. 42. Franchi, L., T. Eigenbrod, R. Munoz-Planillo, and G. Nunez. 2009. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10: 241-247. 43. Franchi, L., T. D. Kanneganti, G. R. Dubyak, and G. Nunez. 2007. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 282: 18810-18818. 44. Kanneganti, T. D., M. Lamkanfi, Y. G. Kim, G. Chen, J. H. Park, L. Franchi, P. Vandenabeele, and G. Nunez. 2007. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26: 433-443. 45. Pelegrin, P., and A. Surprenant. 2007. Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1 beta release through a dye uptake-independent pathway. J Biol Chem 282: 2386-2394. 46. Lamkanfi, M., J. L. Mueller, A. C. Vitari, S. Misaghi, A. Fedorova, K. Deshayes, W. P. Lee, H. M. Hoffman, and V. M. Dixit. 2009. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187: 61-70. 47. Petrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-1589. 48. Halle, A., V. Hornung, G. C. Petzold, C. R. Stewart, B. G. Monks, T. Reinheckel, K. A. Fitzgerald, E. Latz, K. J. Moore, and D. T. Golenbock. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9: 857-865. 49. Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856. 50. Mariathasan, S., D. S. Weiss, V. M. Dixit, and D. M. Monack. 2005. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 202: 1043-1049. 51. Sansonetti, P. J., A. Phalipon, J. Arondel, K. Thirumalai, S. Banerjee, S. Akira, K. Takeda, and A. Zychlinsky. 2000. Caspase-1 activation of IL-1 beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 12: 581-590. 52. Tsuji, N. M., H. Tsutsui, E. Seki, K. Kuida, H. Okamura, K. Nakanishi, and R. A. Flavell. 2004. Roles of caspase-1 in Listeria infection in mice. Int Immunol 16: 335-343. 53. Allen, I. C., M. A. Scull, C. B. Moore, E. K. Holl, E. McElvania-TeKippe, D. J. Taxman, E. H. Guthrie, R. J. Pickles, and J. P. Y. Ting. 2009. The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA. Immunity 30: 556-565. 54. Marodi, L., H. M. Korchak, and R. B. Johnston. 1991. Mechanisms of Host Defense against Candida Species .1. Phagocytosis by Monocytes and Monocyte-Derived Macrophages. Journal of immunology 146: 2783-2789. 55. Taylor, P. R., L. Martinez-Pomares, M. Stacey, H. H. Lin, G. D. Brown, and S. Gordon. 2005. Macrophage receptors and immune recognition. Annu Rev Immunol 23: 901-944. 56. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147. 57. Dinarello, C. A. 1999. IL-18: A T-H1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immun 103: 11-24. 58. Dinarello, C. A. 2000. Proinflammatory cytokines. Chest 118: 503-508. 59. Chung, Y., S. H. Chang, G. J. Martinez, X. X. O. Yang, R. Nurieva, H. S. Kang, L. Ma, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2009. Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling. Immunity 30: 576-587. 60. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. G. Mills. 2009. Interleukin-1 and IL-23 Induce Innate IL-17 Production from gamma delta T Cells, Amplifying Th17 Responses and Autoimmunity. Immunity 31: 331-341. 61. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. 62. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8: 942-949. 63. Rao, D. A., K. J. Tracey, and J. S. Pober. 2007. IL-1 alpha and IL-1 ss are endogenous mediators linking cell injury to the adaptive alloimmune response. Journal of immunology 179: 6536-6546. 64. Latz, E. 2010. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 22: 28-33. 65. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino, and J. V. Oconnor. 1986. Tumor-Necrosis-Factor (Cachectin) Is an Endogenous Pyrogen and Induces Production of Interleukin-1. J Exp Med 163: 1433-1450. 66. Dinarello, C. A., T. Ikejima, S. J. C. Warner, S. F. Orencole, G. Lonnemann, J. G. Cannon, and P. Libby. 1987. Interleukin-1 Induces Interleukin-1 .1. Induction of Circulating Interleukin-1 in Rabbits Invivo and in Human Mononuclear-Cells Invitro. Journal of immunology 139: 1902-1910. 67. Netea, M. G., C. A. Nold-Petry, M. F. Nold, L. A. B. Joosten, B. Opitz, J. H. M. van der Meer, F. L. van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, C. J. Funk, R. J. Mason, B. J. Kullberg, A. Rubartelli, J. W. M. van der Meer, and C. A. Dinarello. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1 beta in monocytes and macrophages. Blood 113: 2324-2335. 68. Kono, H., G. M. Orlowski, Z. Patel, and K. L. Rock. 2012. The IL-1-Dependent Sterile Inflammatory Response Has a Substantial Caspase-1-Independent Component That Requires Cathepsin C. Journal of immunology 189: 3734-3740. 69. Coeshott, C., C. Ohnemus, A. Pilyavskaya, S. Ross, M. Wieczorek, H. Kroona, A. H. Leimer, and J. Cheronis. 1999. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1 beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. P Natl Acad Sci USA 96: 6261-6266. 70. Schonbeck, U., F. Mach, and P. Libby. 1998. Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1 beta processing. Journal of immunology 161: 3340-3346. 71. Cheng, W., P. Shivshankar, Z. Y. Li, L. L. Chen, I. T. Yeh, and G. M. Zhong. 2008. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 76: 515-522. 72. Prantner, D., T. Darville, J. D. Sikes, C. W. Andrews, H. Brade, R. G. Rank, and U. M. Nagarajan. 2009. Critical Role for Interleukin-1 beta (IL-1 beta) during Chlamydia muridarum Genital Infection and Bacterial Replication-Independent Secretion of IL-1 beta in Mouse Macrophages. Infect Immun 77: 5334-5346. 73. Guma, M., L. Ronacher, R. Liu-Bryan, S. Takai, M. Karin, and M. Corr. 2009. Caspase 1-Independent Activation of Interleukin-1 beta in Neutrophil-Predominant Inflammation. Arthritis Rheum 60: 3642-3650. 74. Ippagunta, S. K., D. D. Brand, J. W. Luo, K. L. Boyd, C. Calabrese, R. Stienstra, F. L. Van de Veerdonk, M. G. Netea, L. A. B. Joosten, M. Lamkanfi, and T. D. Kanneganti. 2010. Inflammasome-independent Role of Apoptosis-associated Speck-like Protein Containing a CARD (ASC) in T Cell Priming Is Critical for Collagen-induced Arthritis. J Biol Chem 285: 12454-12462. 75. Joosten, L. A. B., M. G. Netea, G. Fantuzzi, M. I. Koenders, M. M. A. Helsen, H. Sparrer, C. T. Pham, J. W. M. van der Meer, C. A. Dinarello, and W. B. van den Berg. 2009. Inflammatory Arthritis in Caspase 1 Gene-Deficient Mice Contribution of Proteinase 3 to Caspase 1-Independent Production of Bioactive Interleukin-1 beta. Arthritis Rheum 60: 3651-3662. 76. 呂秋瑩. 2012. 靈芝免疫調節蛋白LZ-8和GMI對發炎體活化之作用 In 台灣大學生化科技學系. National Taiwan University, 臺北市. 77. Yin, Y., J. L. Pastrana, X. Li, X. Huang, K. Mallilankaraman, E. T. Choi, M. Madesh, H. Wang, and X. F. Yang. 2013. Inflammasomes: sensors of metabolic stresses for vascular inflammation. Frontiers in bioscience : a journal and virtual library 18: 638-649. 78. Kowaltowski, A. J., N. C. de Souza-Pinto, R. F. Castilho, and A. E. Vercesi. 2009. Mitochondria and reactive oxygen species. Free radical biology & medicine 47: 333-343. 79. Saltoh, S. I. 2009. Chaperones and transport proteins regulate TLR4 trafficking and activation. Immunobiology 214: 594-600. 80. Bauernfeind, F. G., G. Horvath, A. Stutz, E. S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B. G. Monks, K. A. Fitzgerald, V. Hornung, and E. Latz. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. Journal of immunology 183: 787-791. 81. Kayagaki, N., S. Warming, M. Lamkanfi, L. Vande Walle, S. Louie, J. Dong, K. Newton, Y. Qu, J. F. Liu, S. Heldens, J. Zhang, W. P. Lee, M. Roose-Girma, and V. M. Dixit. 2011. Non-canonical inflammasome activation targets caspase-11. Nature 479: 117-U146. 82. Rathinam, V. A., S. K. Vanaja, L. Waggoner, A. Sokolovska, C. Becker, L. M. Stuart, J. M. Leong, and K. A. Fitzgerald. 2012. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150: 606-619. 83. Lin, C. C., Y. L. Yu, C. C. Shih, K. J. Liu, K. L. Ou, L. Z. Hong, J. D. C. Chen, and C. L. Chu. 2011. A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunol Immun 60: 1019-1027. 84. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232. 85. Petrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-1589. 86. Fernandes-Alnemri, T., J. W. Yu, C. Juliana, L. Solorzano, S. Kang, J. Wu, P. Datta, M. McCormick, L. Huang, E. McDermott, L. Eisenlohr, C. P. Landel, and E. S. Alnemri. 2010. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11: 385-393. 87. Arlehamn, C. S., V. Petrilli, O. Gross, J. Tschopp, and T. J. Evans. 2010. The role of potassium in inflammasome activation by bacteria. J Biol Chem 285: 10508-10518. 88. Fernandes-Alnemri, T., J. Wu, J. W. Yu, P. Datta, B. Miller, W. Jankowski, S. Rosenberg, J. Zhang, and E. S. Alnemri. 2007. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14: 1590-1604. 89. Compan, V., A. Baroja-Mazo, G. Lopez-Castejon, A. I. Gomez, C. M. Martinez, D. Angosto, M. T. Montero, A. S. Herranz, E. Bazan, D. Reimers, V. Mulero, and P. Pelegrin. 2012. Cell Volume Regulation Modulates NLRP3 Inflammasome Activation. Immunity 37: 487-500. 90. Hoffmann, E. K., I. H. Lambert, and S. F. Pedersen. 2009. Physiology of Cell Volume Regulation in Vertebrates. Physiol Rev 89: 193-277. 91. Bauernfeind, F., E. Bartok, A. Rieger, L. Franchi, G. Nunez, and V. Hornung. 2011. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. Journal of immunology 187: 613-617. 92. Zhong, Z., Y. Zhai, S. Liang, Y. Mori, R. Han, F. S. Sutterwala, and L. Qiao. 2013. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun 4: 1611. 93. Provoost, S., T. Maes, N. S. Pauwels, T. Vanden Berghe, P. Vandenabeele, B. N. Lambrecht, G. F. Joos, and K. G. Tournoy. 2011. NLRP3/Caspase-1-Independent IL-1 beta Production Mediates Diesel Exhaust Particle-Induced Pulmonary Inflammation. Journal of immunology 187: 3331-3337. 94. Jin, M. S., and J. O. Lee. 2008. Structures of the toll-like receptor family and its ligand complexes. Immunity 29: 182-191. 95. Guarda, G., M. Braun, F. Staehli, A. Tardivel, C. Mattmann, I. Forster, M. Farlik, T. Decker, R. A. Du Pasquier, P. Romero, and J. Tschopp. 2011. Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation. Immunity 34: 213-223. 96. Barkhof, F., C. H. Polman, E. W. Radue, L. Kappos, M. S. Freedman, G. Edan, H. P. Hartung, D. H. Miller, X. Montalban, P. Poppe, M. de Vos, F. Lasri, L. Bauer, S. Dahms, K. Wagner, C. Pohl, and R. Sandbrink. 2007. Magnetic resonance Imaging effects of interferon beta-1b in the BENEFIT study - Integrated 2-year results. Arch Neurol-Chicago 64: 1292-1298. 97. Billiau, A. 2006. Anti-inflammatory properties of Type I interferons. Antivir Res 71: 108-116. 98. Lin, W. H., C. H. Hung, C. I. Hsu, and J. Y. Lin. 1997. Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by a yeast two-hybrid system and site-directed mutagenesis. J Biol Chem 272: 20044-20048. 99. Tschopp, J., and K. Schroder. 2010. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10: 210-215. 100. Feng, X. S., L. T. Krebs, and T. Gridley. 2010. Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion. Development 137: 4191-4199. 101. Meng, G. X., F. P. Zhang, I. Fuss, A. Kitani, and W. Strober. 2009. A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses. Immunity 30: 860-874. 102. Furuya, D. T., A. C. Poletto, R. R. Favaro, J. O. Martins, T. M. T. Zorn, and U. F. Machado. 2010. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. Metabolism 59: 395-399. 103. Rathinam, V. A. K., S. K. Vanaja, L. Waggoner, A. Sokolovska, C. Becker, L. M. Stuart, J. M. Leong, and K. A. Fitzgerald. 2012. TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria. Cell 150: 606-619. 104. Buchholz, U. J., J. M. Ward, E. W. Lamirande, B. Heinze, C. D. Krempl, and P. L. Collins. 2009. Deletion of Nonstructural Proteins NS1 and NS2 from Pneumonia Virus of Mice Attenuates Viral Replication and Reduces Pulmonary Cytokine Expression and Disease. J Virol 83: 1969-1980. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/61584 | - |
dc.description.abstract | IL-1β 為調控先天與後天免疫反應的重要促發炎細胞激素,並且其生成受到發炎體嚴密的機制調控。本篇研究以探討真菌免疫調節蛋白 (fungal immunomodulatory proteins, FIPs) 如何調控發炎體活化及IL-1β的分泌為主軸,先前研究發現給予LZ-8 及 GMI 於經LPS刺激小鼠巨噬細胞,能導致 IL-1β 分泌量上升。此外,添加高濃度氯化鉀於細胞培養液中能顯著降低FIPs所引起的IL-1β分泌量,顯示鉀離子外流對於FIPs 所誘導發炎體活化之重要性,而以dihydrorhodamine 123 (DHR) 螢光 probe 偵測到在FIPs刺激下能產生活性氧自由基 (ROS) ,代表FIPs造成巨噬細胞的發炎體活化需透過鉀離子外流的方式,並且ROS生成亦可能參與活化發炎體的路徑;進一步以 NLRP3-/- 及 ASC-/- 小鼠巨噬細胞進行實驗,結果證實 LZ-8與 GMI 主要調控 IL-1β 生成的路徑是藉由活化 NLRP3 inflammasome 此種發炎體以達成免疫調節,然而以caspase-1 -/- 小鼠進行實驗也發現FIPs的免疫調節作用需藉由 caspase-1活化但並未全然經由caspase-1,其他蛋白酶也可能參與其中。此外以 qRT-PCR 偵測 FIPs 是否具有活化發炎體相關基因表現之第二訊號作用,結果證實 LZ-8 刺激能些微提升巨噬細胞內 IL-1β、NLRP3、caspase-1、caspase-11及type I IFN之基因表現量,並且此作用可能是經由 TLR4 來進行訊號之傳遞。因此本研究證實靈芝免疫調節蛋白 FIPs 同時具有促進發炎體相關基因表現之能力及發炎體組裝之功能,進而引起促發炎細胞激素 IL-1β 的分泌,達到免疫調節的效果。 | zh_TW |
dc.description.abstract | IL-1β is a key proinflammatory cytokine that regulates innate and adaptive immune responses, and the production of IL-1β is precisely controlled by the inflammasome. We previously found that fungal immunomodulatory proteins (FIPs) LZ-8 and GMI could induce IL-1β production in LPS-primed murine macrophages. In this study, we further investigated the mechanisms regulating FIP-induced inflammasome activation and IL-1β secretion. High concentration of KCl in the culture medium significantly suppressed FIP-induced IL-1β production, indicating that potassium efflux plays a vital role in FIP-induced inflammasome activation. Using the fluorescent probe dihydrorhodamine 123 (DHR), ROS production was detected in FIP-treated macrophages, suggesting that ROS generation also plays a role in activation inflammasome. Furthermore, FIP-induced inflammasome activation was strongly attenuated in NLRP3-/- and ASC-/- macrophages, suggesting that LZ-8 and GMI activate the NLRP3 inflammasome in LPS-primed macrophages. However, FIP-induced IL-1β production was only partially reduced in casp-1-/- macrophages, indicating that besides caspase-1, other protease(s) may also contribute to the processing of pro-IL-1β. In addition to providing signal 2 for inflammasome activation, LZ-8 also stimulated the expression of genes encoding IL-1β, NLRP3, caspase-1, caspase-11 and type I IFNs, and TLR4 might be involved in transducing signal. Taken together, our findings provide evidence that FIPs may stimulate both the expression and assembly of inflammasome components, resulting in the production of IL-1β that mediates FIPs immunomodulatory activities. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T13:06:31Z (GMT). No. of bitstreams: 1 ntu-102-R00b22045-1.pdf: 3673949 bytes, checksum: 8516e18528dfbbcdd368f81ebe459a21 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 口試委員會審定書 I
謝誌 II 摘要 III Abstract IV Abbreviation VI 目錄 1 圖表目錄 3 第一章 緒論 4 1.1 靈芝屬真菌 4 1.1.1靈芝屬真菌之功用 4 1.1.2 Ling Zhi-8 (LZ-8) 5 1.1.3 Ganoderma microsprum immunomodulatory protein (GMI) 6 1.3 發炎體 (inflammasome) 7 1.3.1 發炎體的構造及種類 7 1.3.2 發炎體相關基因之調控 8 1.3.3 發炎體的活化途徑 9 1.3.4 發炎體於免疫系統之重要性 10 1.4 Interleukin-1β (IL-1β) 與免疫系統調控 10 1.4.1 IL-1β 於先天免疫系統的角色 11 1.4.2 IL-1β 對後天免疫系統之影響 11 1.4.3 IL-1β 的生成與其下游機制 12 1.5 研究動機與目的 14 第二章 材料與方法 15 2.1 LZ-8 及GMI 15 2.2實驗動物 15 2.3探討LZ-8與GMI活化發炎體的作用 15 2.3.1 培養與刺激骨髓分化之巨噬細胞 15 2.3.2 培養與刺激腹腔巨噬細胞 16 2.3.3 細胞激素分泌量之測定 17 2.3.4 細胞存活率測定 17 2.3.5 蛋白質電泳與西方點墨法 18 2.3.6 離子外流實驗 19 2.3.7 活性氧自由基檢測 19 2.4 LZ-8對於巨噬細胞發炎體相關基因表現量之影響 20 2.4.1萃取刺激後細胞之RNA 20 2.4.2 RNA反轉錄 20 2.4.3 Real-time PCR 21 2.5 統計與繪圖軟體之分析 21 第三章 實驗結果 22 3.1 LZ-8 及 GMI 可活化巨噬細胞中發炎體 22 3.2 LZ-8 及 GMI 活化發炎體之路徑 23 3.2.1 LZ-8及GMI透過鉀離子外流活化發炎體 23 3.2.2 LZ-8 及GMI透過ROS產生活化發炎體 23 3.3 LZ-8 及 GMI 活化 NLRP3 發炎體 24 3.3.1 LZ-8 及 GMI 藉由活化 NLRP3 發炎體生成 IL-1β 24 3.3.2 LZ-8 及 GMI 不完全藉由活化caspase-1 而產生 IL-1β 24 3.4 LZ-8 促進發炎體相關基因表現 25 3.4.1 LZ-8作為第一訊號促進發炎體相關基因表現 25 3.4.2 LZ-8第一訊號作用與TLR4受體之關聯 26 第四章 討論與結論 27 圖表 31 參考文獻 46 | |
dc.language.iso | zh-TW | |
dc.title | 靈芝免疫蛋白 LZ-8 與 GMI 活化發炎體之機制 | zh_TW |
dc.title | Mechanism of Inflammasome Activation by Fungal Immunomodulatory Proteins LZ-8 and GMI | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 徐立中(Li-Chung Hsu),朱清良(Ching-Liang Chu) | |
dc.subject.keyword | 真菌免疫調節蛋白,LZ-8,GMI,發炎體,介白素-1β,活性氧自由基, | zh_TW |
dc.subject.keyword | fugual immunomodulatory proteins (FIPs),Ganoderma lucidium immunomodulatory protein, LZ-8,Ganoderma microsporum immunomodulatory protein, GMI,inflammasome,interleukin-1β (IL-1β),reactive oxygen species (ROS), | en |
dc.relation.page | 55 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-08-02 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科技學系 | zh_TW |
顯示於系所單位: | 生化科技學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 3.59 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。